Data as of Sep 19
| +0.1095 / +6.18%|
The 1 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +59.57% increase from the last price of 1.88.
The current consensus among 1 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.